MDxHealth (MDXH) Income from Continuing Operations (2021 - 2026)
MDxHealth (MDXH) posted Income from Continuing Operations of 8867000.0 for Q1 2026, up 26.55% sequentially from 12072000.0 in Q4 2025, and up 0.76% YoY from 8800027.21 in Q1 2025.
MDxHealth (MDXH) Income from Continuing Operations (2021 - 2026) Analysis & Trends
MDxHealth has reported Income from Continuing Operations for 6 years, with the latest figure at 8867000.0 in Q1 2026.
- Quarterly Income from Continuing Operations rose 0.76% year-over-year to 8867000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 46171766.0 (down 22.41% YoY) and the FY2025 annual result came in at 33519000.0, up 11.95% from the prior year.
- Income from Continuing Operations rose to 8867000.0 in Q1 2026 per MDXH's latest filing, from 12072000.0 in the prior quarter.
- Over five years, Income from Continuing Operations peaked at 71766.0 in Q2 2025 and troughed at 18093730000.0 in Q2 2022.
- A 5-year average of 1074378868.59 and a median of 10626000.0 in 2023 frame the typical range for Income from Continuing Operations.
- The sharpest annual moves came in 2023 and 2025: Income from Continuing Operations jumped 99.94% in 2023, then tumbled 139.38% in 2025.
- Over 5 years, Income from Continuing Operations stood at 12182000.0 in 2022, then rose by 12.02% to 10718000.0 in 2023, then jumped by 37.07% to 6745000.0 in 2024, then sank by 78.98% to 12072000.0 in 2025, then advanced by 26.55% to 8867000.0 in 2026.
- According to Business Quant data, Income from Continuing Operations over the past three periods registered 8867000.0, 12072000.0, and 25161000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.78 Bn | 209.71 Bn | 8.34 Bn | 1.76 Bn |
| 2 | Danaher | 139.83 Bn | 135.48 Bn | 3.61 Bn | 870.00 Mn |
| 3 | Idexx Laboratories | 45.99 Bn | 45.79 Bn | 779.09 Mn | 338.41 Mn |
| 4 | Agilent Technologies | 39.69 Bn | 37.88 Bn | 990.00 Mn | 339.00 Mn |
| 5 | Iqvia Holdings | 39.31 Bn | 37.23 Bn | 1.44 Bn | 241.00 Mn |
| 6 | Natera | 38.74 Bn | 37.64 Bn | 696.04 Mn | -85.11 Mn |
| 7 | Illumina | 29.94 Bn | 28.77 Bn | 770.00 Mn | 207.00 Mn |
| 8 | Mettler Toledo International | 28.55 Bn | 28.50 Bn | 650.22 Mn | 232.90 Mn |
| 9 | Quest Diagnostics | 26.18 Bn | 25.55 Bn | 1.03 Bn | 324.00 Mn |
| 10 | MDxHealth | 21.74 Mn | -21.41 Mn | 16.61 Mn | -8.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.87 Mn |
| Dec 31, 2025 | -12.07 Mn |
| Sep 30, 2025 | -25.16 Mn |
| Jun 30, 2025 | -71,766.00 |
| Mar 31, 2025 | -8.94 Mn |
| Dec 31, 2024 | -6.75 Mn |
| Sep 30, 2024 | -10.51 Mn |
| Jun 30, 2024 | -11.53 Mn |
| Mar 31, 2024 | -8.51 Mn |
| Dec 31, 2023 | -10.72 Mn |
| Sep 30, 2023 | -10.05 Mn |
| Jun 30, 2023 | -10.63 Mn |
| Mar 31, 2023 | -11.71 Mn |
| Dec 31, 2022 | -12.18 Mn |
| Sep 30, 2022 | -14.76 Mn |
| Jun 30, 2022 | -18.09 Bn |
| Mar 31, 2022 | -8.27 Mn |
| Dec 31, 2021 | -8.08 Mn |
| Sep 30, 2021 | -7.62 Mn |